Cholesteatoma Recidivism in Pediatric Versus Adult Patients: Disease Extent and Prognostic Factors
The Laryngoscope · 05.11.2026
DOI: 10.1002/lary.71038 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 05.11.2026. Verfasst von Michal Homolac und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Charles University, Univerzita Karlova v Praze.
Abstract (Originalsprache)
Objective
To determine whether pediatric age independently predicts cholesteatoma recidivism beyond anatomical disease extent using the EAONO/JOS and SAMEO‐ATO classifications.
Methods
A retrospective cohort study of 128 primary cholesteatoma surgeries (128 ears in 126 patients; median follow‐up, 5.8 years) was conducted. Etiology, stage, topographical extension (STAM), and surgical category (SAMEO‐ATO) were recorded. A data‐driven threshold (< 20 years) was identified via maximally selected rank statistics. Predictors were determined by Group Lasso selection and Firth's penalized Cox regression.
Results
Recidivism was identified in 21 of 43 pediatric and 16 of 85 adult ears. The 5‐year cumulative risk was 53.9% (95% CI, 34.2%–67.8%) in children versus 19.1% (95% CI, 9.5%–27.7%) in adults (log‐rank p < 0.001), driven by early residual disease ( p = 0.004) rather than true recurrence ( p = 0.058). The sinus tympani (S2) was a site of recidivism in 38.5% of pediatric versus 5.6% of adult cases ( p = 0.016). Multivariable analysis identified four independent predictors: pediatric age (hazard ratio [HR] 2.24; 95% CI, 1.09–4.63), supratubal recess involvement (HR 3.41; 95% CI, 1.56–7.45), mastoid extension (HR 2.43; 95% CI, 1.01–5.84), and absence of mastoidectomy relative to canal wall‐down technique (HR 8.67; 95% CI, 1.95–38.41).
Conclusion
Pediatric age, supratubal recess involvement, mastoid extension, and mastoidectomy omission relative to canal wall‐down technique independently predict cholesteatoma recidivism. The predominance of residual over recurrent disease, with a median detection interval of approximately 14 months, supports active 12–18 month postoperative surveillance and long‐term clinical follow‐up on a risk‐stratified basis. Level of Evidence 3.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- Department of Otorhinolaryngology and Head and Neck Surgery, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
- Department of Diagnostic Radiology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
ORCID-Profile: Michal Homolac, Anna Svejdova, Lukas Skoloudik, Jan Mejzlik, Viktor Chrobok
Förderung
- Charles University
- Univerzita Karlova v Praze
Zitieren
APA
Homolac, M., Svejdova, A., Skoloudik, L., Mejzlik, J., Dedkova, J., & Chrobok, V. (2026). Cholesteatoma Recidivism in Pediatric Versus Adult Patients: Disease Extent and Prognostic Factors. The Laryngoscope. https://doi.org/10.1002/lary.71038
Vancouver
Homolac M, Svejdova A, Skoloudik L, Mejzlik J, Dedkova J, Chrobok V. Cholesteatoma Recidivism in Pediatric Versus Adult Patients: Disease Extent and Prognostic Factors. The Laryngoscope. 2026. doi:10.1002/lary.71038
BibTeX
@article{Homolac2026,
author = {Homolac, Michal and Svejdova, Anna and Skoloudik, Lukas and Mejzlik, Jan and Dedkova, Jana and Chrobok, Viktor},
title = {Cholesteatoma Recidivism in Pediatric Versus Adult Patients: Disease Extent and Prognostic Factors},
journal = {The Laryngoscope},
year = {2026},
doi = {10.1002/lary.71038}
}
EUVIMED